# A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies

> **NCT07476378** · NA · NOT_YET_RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 69 (estimated)

## Conditions studied

- Lymphoma, Large B-Cell, Diffuse (DLBCL)
- Lymphoma, Follicular
- Lymphoma, Mantle-Cell
- Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Lymphoma, B-Cell, Marginal Zone
- Transformed Follicular Lymphoma (TFL)

## Interventions

- **DRUG:** MTM-H-001 Injection

## Key facts

- **NCT ID:** NCT07476378
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2028-01
- **Final completion:** 2028-06
- **Target enrollment:** 69 (ESTIMATED)
- **Last updated:** 2026-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07476378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07476378, "A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07476378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*